Global

Current Studies

All
Bleeding Disorders
Hereditary Angioedema
Immunoglobulins
Perioperative Bleeding
Pulmonary
Therapeutic Proteins


Condition Additional Trial Information

Primary Immune Deficiency (PID)

Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID)

> Learn More

Von Willebrand Disease

Study of Voncento® in Subjects With Von Willebrand Disease

> Learn More

Hemophilia A

An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A

> Learn More

Hemophilia A With Inhibitors
Hemophilia B With Inhibitors

Study of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) for On-demand Treatment of Bleeding Episodes in Patients With Hemophilia A or B With Inhibitors

> Learn More

Congenital Fibrinogen Deficiency

An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency

> Learn More

Page 1 of 2 Last
Share
LinkedIn Twitter Facebook Google+